Retrospective database analysis of the clinical effect of zoledronic acid on fractures and mortality among patients with genitourinary (GU) cancer and bone metastases (BM) in a managed care plan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback